ADR reporting ? medical content
Pia Caduff
Click the link for copyright information: http://www.who-umc.org/graphics/25569.pdf
Click the link for copyright information: http://www.who-umc.org/graphics/25569.pdf
Titta först på filmen och testa sedan dina kunskaper med detta självrättande test.
Använd koden nedan för att visa denna film på en annan webbsida, till exempel Studentportalen.
Kontaktperson för denna
film
Torbjörn Linnerud, MedfarmDoIT
Uppdaterad
18 juni 2013
Längd
00:40:25
Visningar
2347
För att lägga till denna film till en kanal måste du vara inloggad och ha skapat en kanal.
Kanalinformation
The Study of Adverse Drug Reactions & Related Problems.
For questions about the course and/or lectures: pvtraining@who-umc.org
Fler filmer i denna kanal
-
Pharmacovigilance indicators
Spontaneous reporting
The clinical diagnosis of ADRs
ADR reporting – medical content
ADR reporting – methods and design
Pharmacovigilance data management
Terminologies for coding
ICSR management tool: VigiFlow
Pharmacovigilance methods
Cohort Event Monitoring and CemFlow
The need for pharmacovigilance
Medicines safety in WHO
Being a member of the WHO programme
Pharmacovigilance in Public Health Programmes
Monitoring vaccines – introduction
Safety monitoring of herbals
Electronic health records
Paediatric perspective
SSFFC medical products
Patient safety – medication errors – part 1 of 2
Patient safety – medication errors – part 2 of 2
Patient reporting – patient perspective
Patient reporting in reality
The logic of causality – part 1 of 2
The logic of causality – part 2 of 2
Principles of signal detection – part 1 of 2
Principles of signal detection – part 2 of 2
Potential pitfalls in disproportionality analysis
Benefit-harm assessment
Regulatory aspects of pharmacovigilance
Risk management
From signal to regulatory action
Decision making and medication risk – part 1 of 2
Decision making and medication risk – part 2 of 2
Effective communications – part 1 of 2
Effective communications – part 2 of 2
Influencing audiences - social marketing – part 1 of 2
Influencing audiences - social marketing – part 2 of 2
Pharmacovigilance teaching
Pharmacoepidemiology – introduction
Variability of drug exposure – part 1 of 2
Variability of drug exposure – part 2 of 2